Search

everythinglearnresearchcommunity

for

Search:↓

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

Testosterone's muscle-building effects do not require its conversion to DHT.

Certain drugs that block specific enzymes can help treat prostate diseases.

Rats had lasting erectile problems after stopping a certain medication.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Long-term use of dutasteride can cause permanent erectile dysfunction in rats.

New methods for measuring dutasteride are effective and reliable.

Dutasteride is more effective than finasteride for hair loss treatment.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Two types of 5α-reductase are in dog skin, which might make dutasteride better than finasteride for treating dog hair loss.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.

Finasteride and dutasteride reduce semen quality, with dutasteride having a stronger negative effect.